Health ❯Healthcare ❯Medical Research ❯Clinical Trials

Drug Efficacy

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs

Lecanemab, the first drug to slow Alzheimer's progression, approved by UK regulator but deemed too expensive for NHS use.

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis